VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector

Rhea-AI Summary

VSee Health (Nasdaq:VSEE) announced a multi-year teleradiology contract executed May 7, 2025, with service delivery beginning June 15, 2025, for a premier Level 1 hospital system.

The deal is projected to generate approximately $10 million in gross revenue over the next two years, with provisions for an additional $5M+ in potential revenue, and is described as set to double annual recurring revenue. Revenue recognition has begun and will appear in the company's upcoming Q3 10-Q. The release lists a quoted share price of $0.479 and market cap of $8,123,227.67 as of October 20, 2025.

Positive

• Contract execution on May 7, 2025
• Service delivery started June 15, 2025
• Projected $10 million gross revenue over two years
• Additional $5M+ potential revenue via special provisions
• Expected to double annual recurring revenue
• Revenue recognition began and will appear in Q3 10-Q

Negative

• None.

VSee multi-year teleradiology contract with a major level 1 hospital is set to double annual recurring revenue and pave the path for expanding services across the U.S.

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 21, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a trailblazing leader in telehealth innovation, is thrilled to announce a monumental multi-year teleradiology contract that catapults the Company into a new era of unprecedented growth and shareholder value creation. Executed on May 7, 2025, with service delivery underway since June 15, 2025, this landmark deal with a premier Level 1 hospital system is set to double VSee's annual recurring revenue and unlock a wealth of future opportunities in the rapidly expanding teleradiology market.

This transformative contract is projected to generate approximately $10 million in gross revenues over the next two years. Even more exhilarating, special provisions in the agreement pave the way for an additional $5+ million in potential revenue with similar margins, positioning VSee to capitalize on the surging demand for advanced telehealth solutions. As reflected in the Company's upcoming third quarter 10Q, revenue realization has already begun, marking a pivotal moment for VSee's financial trajectory. Shareholders can view the Company's stock performance details in the finance card above, showcasing VSEE's current price of $0.479 USD and a market cap of $8,123,227.67 as of October 20, 2025.

The teleradiology sector is experiencing explosive growth, driven by the increasing adoption of virtual care and the urgent need for scalable, high-quality diagnostic imaging solutions. VSee's partnership with a major, rapidly expanding hospital system positions the Company at the forefront of this dynamic market, with the potential to secure additional high-value contracts across the U.S. and beyond. Our cutting-edge, API-driven platform-integrating secure video, device data, and EHR connectivity-empowers healthcare providers to deliver world-class care, making VSee the go-to partner for hospitals and health networks seeking innovative telehealth solutions.

"This blockbuster contract is a game-changer for VSee Health and our shareholders," declared Co-CEO Dr. Imo Aisiku. "Doubling our annual recurring revenue is just the beginning. This partnership not only validates our leadership in teleradiology but also opens doors to a pipeline of future contracts with top-tier healthcare systems. We are uniquely positioned to ride the wave of the telehealth revolution, and we expect this to spark a period of explosive growth, delivering substantial value to our investors and transforming the future of healthcare delivery."

With the teleradiology market projected to grow at a compound annual growth rate (CAGR) of over 20% in the coming years, VSee's scalable platform and strategic partnerships position the Company to capture a significant share of this multi-billion-dollar industry. This contract is a springboard for further expansion, with VSee actively pursuing additional partnerships to fuel sustained revenue growth and solidify its dominance in the telehealth landscape.

About VSee Health

VSee Health (NASDAQ: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.

Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements,"; "Risk Factors"; and "Management's Discussion and Analysis of Financial Condition and Results of Operations"; sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Media Contact:
Anne Chang
VSee Health
media@vsee.com

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health, Inc.

View the original press release on ACCESS Newswire

FAQ

What is the value of VSee Health's teleradiology contract (Nasdaq:VSEE)?

The contract is projected to generate approximately $10 million in gross revenue over the next two years with $5M+ potential upside.

When was VSee's teleradiology contract executed and when did service begin for VSEE?

The agreement was executed on May 7, 2025, and service delivery began on June 15, 2025.

How will the teleradiology contract affect VSee Health's recurring revenue (VSEE)?

The company says the contract is set to double annual recurring revenue.

Will VSee (VSEE) recognize revenue from the teleradiology deal in its financial filings?

Yes; revenue realization has begun and will be reflected in the company's upcoming Q3 10-Q.

What customer type is VSee's contract with and how might it affect growth for VSEE?

The multi-year deal is with a premier Level 1 hospital system and is positioned to support expanded U.S. teleradiology growth.

What was VSee's quoted share price and market cap near the announcement?

The release cites a share price of $0.479 and a market cap of $8,123,227.67 as of October 20, 2025.